| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3dded61bd89f99900518597c0958b9a9 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D237-32 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-10 |
| filingDate |
2017-08-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d11e474d267a0cd589c4dee15b3153c3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_216a959ad4fc69ffa0773fc12ed90ed8 |
| publicationDate |
2018-03-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
TW-201806944-A |
| titleOfInvention |
Method for preparing olapa |
| abstract |
Provided herein is the preparation of 4-[(3-[(4-cyclopropylmethylamidino) pyrazine-1-yl] carbonyl) -4-fluorophenyl] methyl (2H) phthalazin-1-one (olapa ) And new processes and methods for their intermediates. Olaparib is a poly ADP ribose polymerase (PARP) inhibitor used to treat cancer. Advantages of the invention include the use of less toxic compounds and improved yields. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TW-I788675-B |
| priorityDate |
2016-08-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |